Karista — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Dbv Technologiesdbv-technologies.comin 𝕏Apr 2025

DBV Technologies is a clinical-stage biopharmaceutical company developing epicutaneous immunotherapy treatments, primarily the VIASKIN patch, for food allergies and immunological diseases.

BiotechDigital HealthMedical Devices

Pharis Mohideen(Executive Officer)Daniel Tasse(Executive Officer, Director)Virginie Boucinha(Executive Officer)Unknown (founded by pediatricians)

BoardMailys Ferrere(Director)Michael Goller(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.